Hemeda Mohamed S, Elsayed Heba A, Mohamad ALMoatazbellah Mahmoud Elsayed, Ibrahim Moustafa M, Farahat Alsayed Magdi Alsayed, Abdel Rahman Abdel Rahman Z, Salama Bassam Mansour, Badawy Ghada Mostafa, Amin Ahmed I, Elyamany Mona Ibrahim, Abdelmottaleb Hatem Ali Ahmed, Ibrahim Mohamed A, Alsaid Aldosoky Abd Elaziz, Elhagary Ahmed A, El-Amir Mostafa I
Department of Forensic Medicine and Clinical Toxicology Faculty of Medicine, Port Said University, Port Said, Egypt.
Department of Microbiology, Faculty of Medicine, Port Said University, Port Said, Egypt.
J Infect Chemother. 2025 Feb;31(2):102533. doi: 10.1016/j.jiac.2024.10.001. Epub 2024 Oct 2.
This cross-sectional study assesses the prevalence of metronidazole resistance-associated mutations and virulence genotypes in Helicobacter pylori (H. pylori) strains isolated from the Egyptian population. H. pylori infection is a significant public health concern, with antibiotic resistance challenging its eradication.
Gastric biopsy samples were collected from symptomatic patients referred for upper gastrointestinal endoscopy at selected healthcare facilities. The study included 250 participants with symptoms suggestive of H. pylori infection and aged 18 years or older. Biopsy samples were obtained using standard endoscopic techniques, and H. pylori strains were isolated and identified in the laboratory. Antimicrobial susceptibility testing was conducted using standard methods. Molecular analysis, including polymerase chain reaction (PCR) and sequencing, was performed to identify metronidazole resistance-associated mutations (rdxA and frxA) and virulence genotypes (cagA and vacA).
Antimicrobial susceptibility testing revealed that 43.6 % of the isolates were resistant to metronidazole, while 11.8 %, 4.5 %, and 55.4 % were resistant to clarithromycin, amoxicillin, and levofloxacin. Molecular analysis identified rdxA and frxA mutations in 36.3 % and 31.8 % of the isolates, respectively, indicating metronidazole resistance-associated mutations. Additionally, 60.0 % of the isolates were positive for the cagA gene, and 80.0 % had the vacA s1 type, both associated with increased virulence. A significant association was found between metronidazole resistance and the presence of cagA gene, vacA s1 type, rdxA mutation, and frxA mutation. Statistical analysis revealed associations between specific mutations and virulence genotypes with respective odds ratios, indicating higher likelihoods of metronidazole resistance in isolates exhibiting these genetic characteristics.
This study highlights the prevalence of metronidazole resistance and the association between specific mutations and virulence genotypes in H. pylori strains isolated from the Egyptian population. The findings underscore the importance of monitoring antibiotic resistance patterns and understanding the genetic determinants of virulence in H. pylori for effective management and treatment strategies.
这项横断面研究评估了从埃及人群中分离出的幽门螺杆菌(H. pylori)菌株中甲硝唑耐药相关突变和毒力基因型的流行情况。幽门螺杆菌感染是一个重大的公共卫生问题,抗生素耐药性对其根除构成挑战。
从选定医疗机构中因上消化道内镜检查而转诊的有症状患者中采集胃活检样本。该研究纳入了250名有幽门螺杆菌感染症状且年龄在18岁及以上的参与者。使用标准内镜技术获取活检样本,并在实验室中分离和鉴定幽门螺杆菌菌株。采用标准方法进行药敏试验。进行分子分析,包括聚合酶链反应(PCR)和测序,以鉴定甲硝唑耐药相关突变(rdxA和frxA)和毒力基因型(cagA和vacA)。
药敏试验显示,43.6%的分离株对甲硝唑耐药,而对克拉霉素、阿莫西林和左氧氟沙星耐药的分别为11.8%、4.5%和55.4%。分子分析分别在36.3%和31.8%的分离株中鉴定出rdxA和frxA突变,表明存在甲硝唑耐药相关突变。此外,60.0%的分离株cagA基因呈阳性,80.0%具有vacA s1型,两者均与毒力增加有关。发现甲硝唑耐药与cagA基因、vacA s1型、rdxA突变和frxA突变的存在之间存在显著关联。统计分析揭示了特定突变与毒力基因型之间的关联以及各自的优势比,表明具有这些遗传特征的分离株对甲硝唑耐药的可能性更高。
本研究突出了从埃及人群中分离出的幽门螺杆菌菌株中甲硝唑耐药的流行情况以及特定突变与毒力基因型之间的关联。这些发现强调了监测抗生素耐药模式以及了解幽门螺杆菌毒力的遗传决定因素对于有效管理和治疗策略的重要性。